US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lakewood-Amedex Biotherapeutics (Direct Listing)

2.50

+0.20008.70%

Post-market: 3.250.7500+30.00%19:04 EDT

Volume:13.35M

Turnover:44.55M

Market Cap:5.92M

PE:-0.25

High:2.58

Open:2.23

Low:2.22

Close:2.30

52wk High:98.20

52wk Low:1.66

Shares:2.37M

Float Shares:1.42M

Volume Ratio:69.85

T/O Rate:943.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.2000

EPS(LYR):-8.3987

ROE:-402.84%

ROA:-139.40%

PB:1.37

PE(LYR):-0.30

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Lakewood-Amedex Q2 FY26 Net Loss Widens to $3.77 Million; R&D Expense More than Doubled to $503,020

Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting

Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting

Lakewood-amedex Biotherapeutics Flags New Press Release Available on Nu-3 Resistance Data

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/LABT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","market":"US","secType":"STK","nameCN":"Lakewood-Amedex Biotherapeutics (Direct Listing)","latestPrice":2.5,"timestamp":1788206400000,"preClose":2.3,"halted":0,"volume":13350573,"hourTrading":{"tag":"盘后","latestPrice":3.25,"preClose":2.5,"latestTime":"19:04 EDT","volume":6667830,"amount":22608243.116784,"timestamp":1788217483941,"change":0.75,"changeRate":0.3,"amplitude":0.508},"delay":0,"changeRate":0.08695652173913052,"floatShares":1415552,"shares":2369700,"eps":-10.199959,"marketStatus":"Post-Mkt","change":0.2,"latestTime":"08-31 19:05:22 EDT","open":2.23,"high":2.58,"low":2.2215,"amount":44554339.925266504,"amplitude":0.15587,"askPrice":3.28,"askSize":20,"bidPrice":3.21,"bidSize":482,"shortable":0,"etf":0,"ttmEps":-10.199959,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"listingDate":1776916800000,"exchange":"NASDAQ","adjPreClose":2.3,"preHourTrading":{"tag":"盘前","latestPrice":2.284,"preClose":2.3,"latestTime":"09:13 EDT","volume":2703,"amount":6202.8592665,"timestamp":1788181990637,"change":-0.016,"changeRate":-0.006957,"amplitude":0.052174},"postHourTrading":{"tag":"盘后","latestPrice":3.25,"preClose":2.5,"latestTime":"19:04 EDT","volume":6667830,"amount":22608243.116784,"timestamp":1788217483941,"change":0.75,"changeRate":0.3,"amplitude":0.508},"volumeRatio":69.851038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","floatShares":1415552,"roa":"-139.40%","roe":"-402.84%","lyrEps":-8.39872,"volumeRatio":69.851038,"shares":2369700,"dividePrice":0,"high":2.58,"amplitude":0.15587,"preClose":2.3,"low":2.2215,"week52Low":1.66,"pbRate":"1.37","week52High":98.2,"institutionHeld":0,"latestPrice":2.5,"committee":0.920319,"eps":-10.199959,"divideRate":0,"volume":13350573,"delay":0,"ttmEps":-10.199959,"open":2.23,"prevYearClose":80,"prevWeekClose":2.3,"prevMonthClose":2.02,"prevQuarterClose":3.14,"fiveDayClose":2.13,"twentyDayClose":2.16,"sixtyDayClose":6.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-06-22","symbol":"LABT","defaultRemindTime":1782135000000,"type":"split","dateTimestamp":1782100800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LABT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LABT","date":"2026-08-28","current":-0.245099,"percent":0.696203,"low":-12.282138,"twenty":-2.760875,"median":-1.18284,"eighty":-0.754039,"high":-0.62611,"avg":-2.607238,"sd":3.246756,"marketCap":5900523},"quantilePoints":[{"date":"2026-05-08","current":-12.282138,"twenty":-12.192813,"median":-11.891342,"eighty":-11.604759,"marketCap":47257207},{"date":"2026-05-15","current":-7.294845,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"marketCap":28067917},{"date":"2026-05-22","current":-2.865088,"twenty":-11.850402,"median":-11.258627,"eighty":-3.412052,"marketCap":11023817},{"date":"2026-05-29","current":-2.716586,"twenty":-11.716415,"median":-6.438817,"eighty":-2.758568,"marketCap":10452435},{"date":"2026-06-05","current":-2.512255,"twenty":-11.604759,"median":-3.225364,"eighty":-2.559299,"marketCap":9666247},{"date":"2026-06-12","current":-2.69016,"twenty":-11.537766,"median":-2.813168,"eighty":-2.512255,"marketCap":10350760},{"date":"2026-06-18","current":-2.241304,"twenty":-11.42611,"median":-2.776507,"eighty":-2.512255,"marketCap":8623724},{"date":"2026-06-26","current":-1.276597,"twenty":-10.242559,"median":-2.72924,"eighty":-2.388094,"marketCap":4911883},{"date":"2026-07-02","current":-1.116845,"twenty":-7.294845,"median":-2.69016,"eighty":-1.477578,"marketCap":4725718},{"date":"2026-07-10","current":-0.893476,"twenty":-5.58279,"median":-2.580737,"eighty":-1.276597,"marketCap":3780575},{"date":"2026-07-17","current":-0.62611,"twenty":-3.536511,"median":-2.512255,"eighty":-1.062695,"marketCap":2649266},{"date":"2026-07-24","current":-1.03562,"twenty":-3.225364,"median":-2.41344,"eighty":-0.92732,"marketCap":4382030},{"date":"2026-07-31","current":-0.653185,"twenty":-2.937143,"median":-2.34533,"eighty":-0.879262,"marketCap":2763829},{"date":"2026-08-07","current":-0.754716,"twenty":-2.857942,"median":-1.477578,"eighty":-0.80819,"marketCap":3193440},{"date":"2026-08-14","current":-0.78856,"twenty":-2.830251,"median":-1.371504,"eighty":-0.793975,"marketCap":3336643},{"date":"2026-08-21","current":-0.706322,"twenty":-2.806803,"median":-1.276597,"eighty":-0.779084,"marketCap":5189616},{"date":"2026-08-28","current":-0.803079,"twenty":-2.760875,"median":-1.18284,"eighty":-0.754039,"marketCap":5900523}],"updateTime":1788206819908},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659110010","title":"Lakewood-Amedex Q2 FY26 Net Loss Widens to $3.77 Million; R&D Expense More than Doubled to $503,020","url":"https://stock-news.laohu8.com/highlight/detail?id=2659110010","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659110010?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:08","pubTimestamp":1786702114,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Q2 FY26 net loss widens to $3.77 million; R&D expense more than doubled to $503,020Lakewood-Amedex posted a net loss of $3.77 million for the quarter ended June 30, 2026, widening from the prior-year period.Operating loss widened to $3.79 million as total operating expenses climbed to $3.79 million.Research and development spending more than doubled to $503,020, driven by higher manufacturing, regulatory and clinical planning for Nu-3 Phase 2a.General and administrative costs jumped to $3.29 million, mainly due to $2.4 million in noncash professional services tied to stock issuance.Series C Convertible Preferred Stock private placement raised about $6.8 million net; common stock began trading on Nasdaq Capital Market on April 23.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL2kZSYf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954040","title":"Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954040","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954040?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:14","pubTimestamp":1786396498,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics announces annual shareholder meetingLakewood-Amedex Biotherapeutics will hold its annual shareholder meeting virtually on Sept. 22, 2026.Shareholders will vote to elect","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL8pvPMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655939386","title":"Lakewood-Amedex Biotherapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2655939386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655939386?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:33","pubTimestamp":1785443614,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics announces annual shareholder meetingLakewood-Amedex Biotherapeutics will hold its annual stockholder meeting virtually on September 22, 2026.Shareholders will vote on e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL4nbJ9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653577357","title":"Lakewood-amedex Biotherapeutics Flags New Press Release Available on Nu-3 Resistance Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2653577357","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653577357?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:04","pubTimestamp":1784721865,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics flags new press release available on Nu-3 resistance dataLakewood-Amedex published a July 22, 2026 release highlighting new resistance data for Nu-3, its Phase 2-ready ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL5F7T3W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABT\",params:#limit:6,delay:false,,,undefined,":[]}}